These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 12933791)
21. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272. Wang YX; Freedberg DI; Yamazaki T; Wingfield PT; Stahl SJ; Kaufman JD; Kiso Y; Torchia DA Biochemistry; 1996 Aug; 35(31):9945-50. PubMed ID: 8756455 [TBL] [Abstract][Full Text] [Related]
22. Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes. Mahalingam B; Louis JM; Hung J; Harrison RW; Weber IT Proteins; 2001 Jun; 43(4):455-64. PubMed ID: 11340661 [TBL] [Abstract][Full Text] [Related]
23. Solution structure of the catalytic domain of gammadelta resolvase. Implications for the mechanism of catalysis. Pan B; Maciejewski MW; Marintchev A; Mullen GP J Mol Biol; 2001 Jul; 310(5):1089-107. PubMed ID: 11501998 [TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus (HIV) type 1 transframe protein can restore activity to a dimerization-deficient HIV protease variant. Dautin N; Karimova G; Ladant D J Virol; 2003 Aug; 77(15):8216-26. PubMed ID: 12857890 [TBL] [Abstract][Full Text] [Related]
25. Illustration of HIV-1 protease folding through a molten-globule-like intermediate using an experimental model that implicates alpha-crystallin and calcium ions. Dash C; Sastry M; Rao M Biochemistry; 2005 Mar; 44(10):3725-34. PubMed ID: 15751949 [TBL] [Abstract][Full Text] [Related]
26. Inhibitor and substrate binding induced stability of HIV-1 protease against sequential dissociation and unfolding revealed by high pressure spectroscopy and kinetics. Ingr M; Lange R; Halabalová V; Yehya A; Hrnčiřík J; Chevalier-Lucia D; Palmade L; Blayo C; Konvalinka J; Dumay E PLoS One; 2015; 10(3):e0119099. PubMed ID: 25781460 [TBL] [Abstract][Full Text] [Related]
27. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions. Seibold SA; Cukier RI Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840 [TBL] [Abstract][Full Text] [Related]
28. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations. Rose RB; Craik CS; Stroud RM Biochemistry; 1998 Feb; 37(8):2607-21. PubMed ID: 9485411 [TBL] [Abstract][Full Text] [Related]
29. A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease. Dohnálek J; Hasek J; Dusková J; Petroková H; Hradilek M; Soucek M; Konvalinka J; Brynda J; Sedlácek J; Fábry M Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):472-6. PubMed ID: 11223536 [TBL] [Abstract][Full Text] [Related]
30. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. Bader R; Bettio A; Beck-Sickinger AG; Zerbe O J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908 [TBL] [Abstract][Full Text] [Related]
31. Structure-based thermodynamic analysis of caspases reveals key residues for dimerization and activity. Piana S; Sulpizi M; Rothlisberger U Biochemistry; 2003 Jul; 42(29):8720-8. PubMed ID: 12873132 [TBL] [Abstract][Full Text] [Related]
32. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements. Reiling KK; Pray TR; Craik CS; Stroud RM Biochemistry; 2000 Oct; 39(42):12796-803. PubMed ID: 11041844 [TBL] [Abstract][Full Text] [Related]
33. Anisotropic dynamics of the JE-2147-HIV protease complex: drug resistance and thermodynamic binding mode examined in a 1.09 A structure. Reiling KK; Endres NF; Dauber DS; Craik CS; Stroud RM Biochemistry; 2002 Apr; 41(14):4582-94. PubMed ID: 11926820 [TBL] [Abstract][Full Text] [Related]
34. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling. Frutos S; Rodriguez-Mias RA; Madurga S; Collinet B; Reboud-Ravaux M; Ludevid D; Giralt E Biopolymers; 2007; 88(2):164-73. PubMed ID: 17236209 [TBL] [Abstract][Full Text] [Related]
36. A folding inhibitor of the HIV-1 protease. Broglia RA; Provasi D; Vasile F; Ottolina G; Longhi R; Tiana G Proteins; 2006 Mar; 62(4):928-33. PubMed ID: 16385559 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive mutagenesis of HIV-1 protease: a computational geometry approach. Masso M; Vaisman II Biochem Biophys Res Commun; 2003 May; 305(2):322-6. PubMed ID: 12745077 [TBL] [Abstract][Full Text] [Related]
38. Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR. Deshmukh L; Tugarinov V; Louis JM; Clore GM Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9855-E9862. PubMed ID: 29087351 [TBL] [Abstract][Full Text] [Related]
39. Role of the amino acid sequence in domain swapping of the B1 domain of protein G. Sirota FL; Héry-Huynh S; Maurer-Stroh S; Wodak SJ Proteins; 2008 Jul; 72(1):88-104. PubMed ID: 18186476 [TBL] [Abstract][Full Text] [Related]